The Hematology/Oncology Fellowship Program offers multiple formal didactic programs to the fellows.
University of Pittsburgh and UPMC faculty present a weekly didactic lecture series on both basic and state-of-the-art clinical and research topics.
John Kirkwood, MD, Section Director, Melanoma Program
In addition, fellows have the opportunity to participate in:
- Clinical oncology and hematology grand rounds
- Department of Internal Medicine grand rounds
- Numerous multidisciplinary tumor boards and conferences
Fellows and attendings also participate in a weekly:
- Fellows case conference series with interactive fellow-driven discussions on the diagnosis and management of specific cases.
- Journal club where fellows are taught to critically review literature with the added guidance of the biostatistics faculty.
- Writing group to hone their skills in the preparation and presentation of abstracts, manuscripts, and grant applications.
Clinical Oncology and Hematology Grand Rounds
- Clinical Oncology and Hematology Grand Rounds meet every Wednesday morning from 8 to 9 a.m. at UPMC Shadyside during the academic year. The course director for this program is Robert Redner, MD, professor of medicine.
- The goal of the program is to review and update physicians and other clinical staff on the latest advances in multidisciplinary care of hematologic and oncologic disease. Speakers are from a range of disciplines and may be from the University of Pittsburgh or other institutions from across the country.
- The University of Pittsburgh School of Medicine is accredited by the ACCME to provide continuing medical education for physicians, and designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Other health care professionals are awarded continuing education units (CEUs) that are equal to one contact hour.
More Learning Opportunities for Hematology/Oncology Fellows
The UPMC Hematology/Oncology Fellowship Program offers a number of unique learning opportunities.
Via Oncology Pathways™
Via Oncology Pathways™ is a web-based decision-support tool to which hematology/oncology fellows are exposed throughout the program. Developed by oncologists at UPMC Hillman Cancer Center in 2005, Via Oncology Pathways™ arose from a need to ensure quality and consistency of care across a network of almost 200 providers at more than 30 sites. Today, Via Oncology Pathways™ are incorporated throughout the UPMC Hillman Cancer Center network and assist with quality, safety, efficiency, and outcomes of care for cancer patients at medical and radiation oncology centers throughout the world.
Hillman Annual Scientific Retreat
Hillman offers a two-day Scientific Retreat each year that focuses on highlighting the work of more than 400 Hillman scientists. The retreat usually includes a keynote lecture, poster sessions, and break-out sessions, and an opportunity to network informally. Hematology/oncology fellows are invited to participate and present posters during the retreat.
Oncology Drug Discovery & Development Workshop
On May 11, 2012, the Division of Hematology/Oncology hosted an Oncology Drug Discovery & Development Workshop in cooperation with Matthew Cotter, PhD, of Pfizer Oncology.
During the workshop, attendees role-played as members of a team whose goal was to discover and develop a drug that meets FDA approval. This allowed participants to get a firsthand experience of the process and learn what each role does.
The workshop received positive and successful feedback from participants. Fellows from the Hematology/Oncology Fellowship Program attended the workshop, as well as five UPMC third-year residents, three of whom entered the Division of Hematology/Oncology Fellowship Program that month.